124315-36-2

Basic information

• Product Name: 4,5-diaza-9-diazo-9H-fluorene
• CAS NO: 124315-36-2
• Molecular Weight: 194.195
• Mol File: 124315-36-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4,5-diaza-9-diazo-9H-fluorene(CAS DataBase Reference)
• NIST Chemistry Reference: 4,5-diaza-9-diazo-9H-fluorene(124315-36-2)
• EPA Substance Registry System: 4,5-diaza-9-diazo-9H-fluorene(124315-36-2)

Safety Data

• Hazardous Substances Data: 124315-36-2(Hazardous Substances Data)

Upstream product

• 90299-45-9 4,5-diazafluorenone-9-hydrazone 
• 50890-67-0 4,5-Diazafluoren-9-one 

Downstream Products

• 1169969-39-4 (2R,5S,6S,7R)-1,4',5'-triazaspiro[7-ethoxycarbonyl-3-oxa-8-oxo-2-phenyl-tricyclo[4.3.0^1,5.0^6,7]nonane-9,9′-fluorene] 
• 124315-41-9 4,5-Diazafluorene-9-spiro-1'-(2'-methyl-2'-phenyl)cyclopropane 
• 124315-40-8 4,5-Diazafluorene-9-spiro-1'-(trans-2'-methyl-3'-phenyl)cyclopropane 
• 124315-38-4 4,5-Diazafluorene-9-spiro-1'-(2'-phenyl)cyclopropane 
• 90299-47-1 5,5'-hydrazine-1,2-diylidene-bis(5H-pyrido[3',2':4,5]cyclopenta[1,2-b]pyridine) 
• 124315-39-5 4,5-Diazafluorene-9-spiro-1',2'-(p-methylphenyl)cyclopropane 

Relevant articles and documents

Substituted diaryldiazomethanes and diazofluorenes: Structure, reactivity and stability

The synthesis of several substituted diaryldiazomethanes and diazofluorenes, and an assessment of their structure, reactivity and stability, is reported.

Synthesis of new rigid, bridging ligands for the study of energy and electron-transfer reactions

The synthesis and characterization of rigid, rod-like, bridging ligands with an adamantane spacer and two 4,5-diazafluorene, or 1,10-phenanthroline chelating units, respectively, are described.

Compounds, composition, and methods for photodynamic therapy

Disclosed are novel compounds, compositions, and methods that are particularly useful in photodynamic therapy. In particular, the inventive compounds, compositions, and methods relate to the formation of cytotoxic radical species in the presence of light. Significantly, the compounds, compositions, and methods of the present invention do not require the presence of oxygen in the photodynamic therapy and, as such, rely on a unimolecular mechanism for producing the radicals. The inventive compounds, compositions, and methods can be used, for example, in the treatment of cancers as well as infections caused by microorganisms such as protozoa, fungi, bacteria, and viruses.